Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy
Conclusions
Use of ripasudil as an adjunctive therapy resulted in lowering of the IOP. Ripasudil was well tolerated.
Funding
Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (26462689).
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Allergy & Immunology | Blepharitis | Drugs & Pharmacology | Education | Glaucoma | Grants | Science | Sports Medicine | Study | Universities & Medical Training